Navigation Links
Pop a pill once a month and free yourself from alcoholism

FDA has approved a new drug to treat alcoholism by taking it just once a month.

Alkermes Inc. and Cephalon Inc. launched the drug, // Vivitrol, an injectable form of naltrexone administered monthly to help control cravings for alcohol.

ReVia by Barr Pharmaceuticals Inc. is how the pill is sold generically.

This drug would be freely available by June end and in the form of a single dose, 380-milligram intramuscular injection.

Vivitrol was granted a conditional approval by FDA in December but said the companies had to provide more data before a final decision could be made, pushing final approval back by more than three months.

The deal is between two companies where the drug was developed by Alkermes, which will manufacture Vivitrol, while Cephalon takes on marketing and sales responsibilities.

The drug’s prescription would be in conjunction with therapy for patients who are able to abstain from drinking in an outpatient setting and are not actively drinking when initiating treatment. This was told by the companies.
'"/>




Page: 1

Related medicine news :

1. Exclusive breast-feeding advised for six months in infants recommends World Health Organization
2. Winter months encourage binge eating
3. Birth month can affect your fertility
4. Vitamin D Supplement in Teenage Girls essential in Winter months
5. Vitamin D Supplement in Teenage Girls essential in Winter months
6. NABH Health accreditations final draft to be released by this month
7. Happiness in the wake of quake: 7,000 births every month
8. Parents Concerned over 16-month-old boy’s Overweigh
9. NHS De-addiction, Rehabilitation waiting time ticking into months
10. HIV/AIDS prevention program extended by 18 months in Bangladesh
11. Even 6 months or more of hormone therapy treatment does not impact longevity of prostate cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/9/2016)... ... 09, 2016 , ... Dr. Rassouli, cosmetic dentist in Orange County , ... most popular cosmetic procedures in dentistry today, but the cost often leads to patients ... risk of teeth whitening-related damage. For a limited time, Dr. Rassouli is offering this ...
(Date:2/9/2016)... ... 2016 , ... United Methodist Communications collaborated with Chocolate Moose ... video designed to prevent the next widespread Ebola outbreak from occurring ... distributed throughout Togo, Liberia, Sierra Leone, Nigeria, Côte d’Ivoire and other African countries, ...
(Date:2/8/2016)... ... ... CURE Media Group , the nation’s leading digital and print media enterprise ... , which will annually honor individuals making heroic contributions in the field of multiple ... Awards nomination process is officially open through February 17 for patients, caregivers and ...
(Date:2/8/2016)... ... February 08, 2016 , ... The Valentine’s Season is famous for gift giving with flowers, ... that they are loved. This year, for more than 5.6 million Americans suffering with ... won't be enough to remind them of the lives they’ve led and the people they’ve ...
(Date:2/8/2016)... ... February 08, 2016 , ... Steve Helwig & Associates Insurance & Financial, serving ... program, has teamed up with Citizens Opposed to Domestic Abuse in support of its ... support all those victimized by the fear of violence in their own homes, donations ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... LONDON , Feb. 9, 2016 The new report ... Spearhead Acuity Business Research & Consulting group reveals that the ... market with a share of 38.9% in 2014 that translated into ... , Europe , Asia-Pacific ... and Africa . The global anti-bacterial market ...
(Date:2/8/2016)... Feb.8, 2016 Respiratory Devices - Medical ... Medical Devices sector report, " Respiratory Devices - ... overview of Respiratory Devices currently in pipeline stage. ... pipeline products with comparative analysis of the products ... major players involved in the pipeline product development. ...
(Date:2/8/2016)... FAIRFIELD, N.J. , Feb. 8, 2016  Otsuka ... today announced that they have entered into a licensing ... OPA-15406 in the U.S. and Puerto Rico ... is a topical, non-steroidal phosphodiesterase IV (PDE-4) inhibitor, a ... --> --> In a Phase II ...
Breaking Medicine Technology: